Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuki Katayama

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Translational Lung Cancer Research|August 13, 2025
Lorlatinib in ALK-positive non-small cell lung cancer: final survival data that reshape the therapeutic landscapeYuki Katayama
Seikagaku. the Journal of Japanese Biochemical Society|August 4, 2016
[Why Won't the Intractable MRSA Infections Go Away?]Yuki Katayama
Microbial Drug Resistance (Larchmont, N.Y.)|March 6, 2004
Effect of disruption of Staphylococcus aureus PBP4 gene on resistance to beta-lactam antibioticsYuki Katayama, Hong-Zhong Zhang, Henry F Chambers
International Journal of Medical Microbiology : IJMM|August 28, 2002
Molecular genetics of methicillin-resistant Staphylococcus aureusKeiichi Hiramatsu, Yuki Katayama, Harumi Yuzawa, et al.
Organic Letters|March 3, 2023
Fluorinated 2,6-Xylenesulfonyl Group: A Protective Group for AminesYuki Katayama, Kenta Watanabe, Yoshitake Nishiyama, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2004
PBP 2a mutations producing very-high-level resistance to beta-lactamsYuki Katayama, Hong-Zhong Zhang, Henry F Chambers
Journal of Agricultural and Food Chemistry|May 17, 2026
Volatile Compounds from <i>Vishniacozyma victoriae</i> Induce Glandular Trichome Development in <i>Humulus lupulus</i>Takeshi Hirakawa, Yuki Katayama, Nariaki Wasano, et al.
Antimicrobial Agents and Chemotherapy|May 6, 2015
A mutation of RNA polymerase β' subunit (RpoC) converts heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) into "slow VISA"Miki Matsuo, Tomomi Hishinuma, Yuki Katayama, et al.
Respirology Case Reports|May 30, 2019
Multiple primary lung adenocarcinomas pre-operatively diagnosed by discordant epidermal growth factor receptor mutationsYuki Katayama, Sayaka Kawai, Aya Miyagawa-Hayashino, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2009
Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenemYuki Katayama, Hiroko Murakami-Kuroda, Longzhu Cui, et al.
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Translational Lung Cancer Research|August 13, 2025
Lorlatinib in ALK-positive non-small cell lung cancer: final survival data that reshape the therapeutic landscapeYuki Katayama
Seikagaku. the Journal of Japanese Biochemical Society|August 4, 2016
[Why Won't the Intractable MRSA Infections Go Away?]Yuki Katayama
Microbial Drug Resistance (Larchmont, N.Y.)|March 6, 2004
Effect of disruption of Staphylococcus aureus PBP4 gene on resistance to beta-lactam antibioticsYuki Katayama, Hong-Zhong Zhang, Henry F Chambers
International Journal of Medical Microbiology : IJMM|August 28, 2002
Molecular genetics of methicillin-resistant Staphylococcus aureusKeiichi Hiramatsu, Yuki Katayama, Harumi Yuzawa, et al.
Organic Letters|March 3, 2023
Fluorinated 2,6-Xylenesulfonyl Group: A Protective Group for AminesYuki Katayama, Kenta Watanabe, Yoshitake Nishiyama, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2004
PBP 2a mutations producing very-high-level resistance to beta-lactamsYuki Katayama, Hong-Zhong Zhang, Henry F Chambers
Journal of Agricultural and Food Chemistry|May 17, 2026
Volatile Compounds from <i>Vishniacozyma victoriae</i> Induce Glandular Trichome Development in <i>Humulus lupulus</i>Takeshi Hirakawa, Yuki Katayama, Nariaki Wasano, et al.
Antimicrobial Agents and Chemotherapy|May 6, 2015
A mutation of RNA polymerase β' subunit (RpoC) converts heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) into "slow VISA"Miki Matsuo, Tomomi Hishinuma, Yuki Katayama, et al.
Respirology Case Reports|May 30, 2019
Multiple primary lung adenocarcinomas pre-operatively diagnosed by discordant epidermal growth factor receptor mutationsYuki Katayama, Sayaka Kawai, Aya Miyagawa-Hayashino, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2009
Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenemYuki Katayama, Hiroko Murakami-Kuroda, Longzhu Cui, et al.
Pageof 11